Elmed Life Sciences, a company specializing in probiotic and biological solutions for animal health, aquaculture, agriculture, and human health, has successfully raised $2.7 million in funding from Agrisure Fund. The investment was facilitated by Nabard-backed Nabventures, showcasing the growing interest in innovative solutions across various sectors.
This funding round is expected to support Elmed Life Sciences’ research and development efforts, enabling the company to enhance its product offerings and expand its market reach. With a focus on utilizing technology to advance health solutions, Elmed Life Sciences is poised to make significant strides in addressing critical challenges in animal and human health sectors.
By securing this investment, Elmed Life Sciences demonstrates the industry’s confidence in the potential of probiotic and biological solutions. The backing from Agrisure Fund validates the company’s approach and highlights the importance of technological advancements in revolutionizing traditional health practices.
Source: Tech-Economic Times